Species vulnerability to climate change: impacts on spatial conservation priorities and species representation

Climate change may shrink and/or shift plant species ranges thereby increasing their vulnerability and requiring targeted conservation to facilitate adaptation. We quantified the vulnerability to climate change of plant species based on exposure, sensitivity and adaptive capacity and assessed the effects of including these components in complementarity‐based spatial conservation prioritisation. We modelled the vulnerability of 584 native plant species under three climate change scenarios in an 11.9 million hectare fragmented agricultural region in southern Australia. We represented exposure as species' geographical range under each climate change scenario as quantified using species distribution models. We calculated sensitivity as a function of the impact of climate change on species' geographical ranges. Using a dispersal kernel, we quantified adaptive capacity as species' ability to migrate to new geographical ranges under each climate change scenario. Using Zonation, we assessed the impact of individual components of vulnerability (exposure, sensitivity and adaptive capacity) on spatial conservation priorities and levels of species representation in priority areas under each climate change scenario. The full vulnerability framework proved an effective basis for identifying spatial conservation priorities under climate change. Including different dimensions of vulnerability had significant implications for spatial conservation priorities. Incorporating adaptive capacity increased the level of representation of most species. However, prioritising sensitive species reduced the representation of other species. We conclude that whilst taking an integrated approach to mitigating species vulnerability to climate change can ensure sensitive species are well‐represented in a conservation network, this can come at the cost of reduced representation of other species. Conservation planning decisions aimed at reducing species vulnerability to climate change need to be made in full cognisance of the sensitivity of spatial conservation priorities to individual components of vulnerability, and the trade‐offs associated with focussing on sensitive species.     

Neuropeptide Y Gene Polymorphisms Confer Risk of Early-Onset Atherosclerosis

Neuropeptide Y (NPY) is a strong candidate gene for coronary artery disease (CAD). We have previously identified genetic linkage to familial CAD in the genomic region of NPY. We performed follow-up genetic, biostatistical, and functional analysis of NPY in early-onset CAD. In familial CAD (GENECARD, N=420 families), we found increased microsatellite linkage to chromosome 7p14 (OSA LOD=4.2, p=0.004) in 97 earliest age-of-onset families. Tagged NPY SNPs demonstrated linkage to CAD of a 6-SNP block (LOD=1.58–2.72), family-based association of this block with CAD (p=0.02), and stronger linkage to CAD in the earliest age-of-onset families. Association of this 6-SNP block with CAD was validated in: (a) 556 non-familial early-onset CAD cases and 256 controls (OR 1.46–1.65, p=0.01–0.05), showing stronger association in youngest cases (OR 1.84–2.20, p=0.0004–0.09); and (b) GENECARD probands versus non-familial controls (OR 1.79–2.06, p=0.003–0.02). A promoter SNP (rs16147) within this 6-SNP block was associated with higher plasma NPY levels (p=0.04). To assess a causal role of NPY in atherosclerosis, we applied the NPY1-receptor–antagonist BIBP-3226 adventitially to endothelium-denuded carotid arteries of apolipoprotein E-deficient mice; treatment reduced atherosclerotic neointimal area by 50% (p=0.03). Thus, NPY variants associate with atherosclerosis in two independent datasets (with strong age-of-onset effects) and show allele-specific expression with NPY levels, while NPY receptor antagonism reduces atherosclerosis in mice. We conclude that NPY contributes to atherosclerosis pathogenesis.     

Parasite and mammalian GPI biosynthetic pathways can be distinguished using synthetic substrate analogues.

Glycosylphosphatidylinositol (GPI) structures are attached to many cell surface glycoproteins in lower and higher eukaryotes. GPI structures are particularly abundant in trypanosomatid parasites where they can be found attached to complex phosphosaccharides, as well as to glycoproteins, and as mature surface glycolipids. The high density of GPI structures at all life-cycle stages of African trypanosomes and Leishmania suggests that the GPI biosynthetic pathway might be a reasonable target for the development of anti-parasite drugs. In this paper we show that synthetic analogues of early GPI intermediates having the 2-hydroxyl group of the D-myo-inositol residue methylated are recognized and mannosylated by the GPI biosynthetic pathways of Trypanosoma brucei and Leishmania major but not by that of human (HeLa) cells. These findings suggest that the discovery and development of specific inhibitors of parasite GPI biosynthesis are attainable goals. Moreover, they demonstrate that inositol acylation is required for mannosylation in the HeLa cell GPI biosynthetic pathway, whereas it is required for ethanolamine phosphate addition in the T.brucei GPI biosynthetic pathway.     

Potent vasoactive properties of endothelin 1 in human skin.

The effect of the endothelial cell-derived peptide endothelin 1 was investigated in human skin. Intradermal injection of endothelin 1 (1-100 pmol) caused a dose-dependent area of pallor that was associated with a significant reduction in basal skin blood flow, measured by laser-Doppler blood flowmeter (with 1 pmol endothelin, P = 0.012, analysis of variance). The coadministration of endothelin 1 (1-100 pmol) with the neuropeptide vasodilator calcitonin gene-related peptide (CGRP) inhibited the vasodilator response to CGRP (10 pmol) by up to 82.7 +/- 9.2% (with 100 pmol endothelin, P less than 0.001). The response of the prostanoid vasodilator prostaglandin E2 (10 pmol) was inhibited by endothelin in a similar manner. In addition to the vasoconstrictor effects, endothelin 1 produced a dose-dependent flare that surrounded the area of pallor, and this was associated with a significant increase in blood flow (P less than 0.05) within the flare area. The H1 antagonist terfenadine (120 mg po) significantly reduced the flare area associated with endothelin 1: flare 5 min after intradermal endothelin (10 pmol, placebo treated), 668 +/- 405 mm2; terfenadine treated, 201 +/- 257 mm2 (P less than 0.05). The flare was also significantly attenuated when endothelin (10 pmol) was injected into local anesthetic-treated skin. Thus intradermal injection of endothelin in humans causes long-lasting vasoconstriction at the site of injection and a surrounding flare. Results suggest that the flare component is partially histamine dependent and the result of an axon reflex. This study demonstrates the potent activity of endothelin in human skin. It is possible that endothelin could be relevant to the local response of skin to injury.     

Synthesis of some second-generation substrate analogues of early intermediates in the biosynthetic pathway of glycosylphosphatidylinositol membrane anchors

1-D-6-O-(2-Amino-2-deoxy-alpha-D-glucopyranosyl)-2-O-octyl-myo-inositol 1-(1,2-di-O-hexadecanoyl-sn-glycerol 3-phosphate) (23) and the corresponding 2-O-hexadecyl-D-myo-inositol compound 24 have been prepared as substrate analogues of an early intermediate in the biosynthetic pathway of glycosylphosphatidylinositol (GPI) membrane anchors. 1-D-6-O-(2-Amino-2-deoxy-alpha-D-glucopyranosyl)-myo-inositol 1-(1,2-di-O-octyl-sn-glycerol 3-phosphate) has also been prepared as a substrate analogue. Biological evaluation of the analogues 23 and 24 revealed that they are neither substrates nor inhibitors of GPI biosynthetic enzymes in the human (HeLa) cell-free system but are potent inhibitors at different stages of GPI biosynthesis in the Trypanosoma brucei cell-free system.     

Displacement,and home range movements of muskellunge determined by ultrasonic tracking

Synopsis Five adult or subadult muskellunge, Esox masquinongy (Salmoniformes: Esocoidei), were tracked over periods of 6–11 days by means of ultrasonic (74 ± 1 Khz) transmitters, surgically implanted in the body cavity. One of these fish demonstrated that survival and well-being for over a year is probable. There was no apparent effect on equilibrium, swimming, or feeding. There was also no apparent abnormally high amount of movement immediately after release.Signal range was at times no greater than 10 m (in contrast to a potential of 1 km) as a result of the air in the dense aquatic vegetation.Area occupied by a single individual for a protracted period could be described as a linear distance of 300–800 m in the stream, or a circle 300 m in diamter in the lake. Displaced individuals returned to a specific locality. Following spawning they do so over a distance as great as 6.4 km in a maximum of two days. There was evidence that two individuals used the same general area simultaneously.Subsequent results with some of the same individuals indicated that radio transmitters are more practical and yield better results in the situation under study.     

THE ACTION SPECTRUM OF SENSITIZATION TO HEAT WITH ULTRAVIOLET LIGHT

1. Heat does not sensitize paramecia to ultraviolet light but ultraviolet light sensitizes them to heat. Paramecia of two species (Paramecium caudatum and P. multimicronucleate) are much more readily killed by heat at 42.3° C. if they are first exposed to ultraviolet light. 2. From studies on paramecia irradiated with a given dosage at various wave lengths before being killed by heat, an action spectrum of the compound in the protoplasm being sensitized to heat can be determined. Proteins with absorption similar to that of pseudoglobulin are suggested by these experiments. 3. The effect upon living things differs from that on pure protein systems in that paramecia are not rendered more sensitive to temperatures below the lethal temperature whereas proteins are. 4. Almost complete recovery from ultraviolet light as judged by heat sensitivity occurs within 4 to 5 days. 5. By a study of the rate of recovery from doses at different wave lengths evidence suggesting effects on nucleic acid is obtained. 6. The possible significance of the data and the action spectrum is discussed.     

Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design

The death of CD4⁺ CCR5⁺ T cells is a hallmark of human immunodeficiency virus (HIV) infection. We studied the plasma levels of cell death mediators and products—tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), Fas ligand, TNF receptor type 2 (TNFR-2), and plasma microparticles—during the earliest stages of infection following HIV type 1 (HIV-1) transmission in plasma samples from U.S. plasma donors. Significant plasma TRAIL level elevations occurred a mean of 7.2 days before the peak of plasma viral load (VL), while TNFR-2, Fas ligand, and microparticle level elevations occurred concurrently with maximum VL. Microparticles had been previously shown to mediate immunosuppressive effects on T cells and macrophages. We found that T-cell apoptotic microparticles also potently suppressed in vitro immunoglobulin G (IgG) and IgA antibody production by memory B cells. Thus, release of TRAIL during the onset of plasma viremia (i.e., the eclipse phase) in HIV-1 transmission may initiate or amplify early HIV-1-induced cell death. The window of opportunity for a HIV-1 vaccine is from the time of HIV-1 transmission until establishment of the latently infected CD4⁺ T cells. Release of products of cell death and subsequent immunosuppression following HIV-1 transmission could potentially narrow the window of opportunity during which a vaccine is able to extinguish HIV-1 infection and could place severe constraints on the amount of time available for the immune system to respond to the transmitted virus.